GINO BIOW Share Price Nasdaq
Equities
DNA
US37611X1000
Biotechnology & Medical Research
Sales 2024 * | 199M 15.92B | Sales 2025 * | 265M 21.14B | Capitalization | 1.68B 134B |
---|---|---|---|---|---|
Net income 2024 * | -569M -45.44B | Net income 2025 * | -479M -38.26B | EV / Sales 2024 * | 5.33 x |
Net cash position 2024 * | 613M 48.97B | Net cash position 2025 * | 557M 44.47B | EV / Sales 2025 * | 4.23 x |
P/E ratio 2024 * |
-2.43
x | P/E ratio 2025 * |
-3
x | Employees | 1,218 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.67% |
Latest transcript on GINO BIOW
Managers | Title | Age | Since |
---|---|---|---|
Austin Che
FOU | Founder | - | 31/12/07 |
Founder | - | 31/12/07 | |
Reshma Shetty
FOU | Founder | 43 | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 15/09/21 |
Arie Belldegrun
BRD | Director/Board Member | 74 | 31/12/20 |
Marijn Dekkers
CHM | Chairman | 65 | 15/09/21 |
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |